Source: Program & Abstracts. Conference titles: The Endocrine Society's Annual Meeting. Unidade: FM
Assunto: METABOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SZTEINSZNAJD, C. et al. Estrogen therapy (Conjugated Estrogen-CE-0,625mg/d) did not improve fibrinolysis and carbohydrate metabolism (CHO)in postmenopausal women with type 2 diabetes mellitus (DM). 2000, Anais.. Toronto: Faculdade de Medicina, Universidade de São Paulo, 2000. . Acesso em: 18 maio 2024.APA
Szteinsznajd, C., Silva, M. E. R., Nussbacher, A., Rocha, T. R. F., Mello, N., Gebara, O. E., et al. (2000). Estrogen therapy (Conjugated Estrogen-CE-0,625mg/d) did not improve fibrinolysis and carbohydrate metabolism (CHO)in postmenopausal women with type 2 diabetes mellitus (DM). In Program & Abstracts. Toronto: Faculdade de Medicina, Universidade de São Paulo.NLM
Szteinsznajd C, Silva MER, Nussbacher A, Rocha TRF, Mello N, Gebara OE, Fukui RT, Wajchenberg BL, Santos RF, Damico E, Lage SG, Waijgarten M, Rocha DM, Ursich MJM. Estrogen therapy (Conjugated Estrogen-CE-0,625mg/d) did not improve fibrinolysis and carbohydrate metabolism (CHO)in postmenopausal women with type 2 diabetes mellitus (DM). Program & Abstracts. 2000 ;[citado 2024 maio 18 ]Vancouver
Szteinsznajd C, Silva MER, Nussbacher A, Rocha TRF, Mello N, Gebara OE, Fukui RT, Wajchenberg BL, Santos RF, Damico E, Lage SG, Waijgarten M, Rocha DM, Ursich MJM. Estrogen therapy (Conjugated Estrogen-CE-0,625mg/d) did not improve fibrinolysis and carbohydrate metabolism (CHO)in postmenopausal women with type 2 diabetes mellitus (DM). Program & Abstracts. 2000 ;[citado 2024 maio 18 ]